đź“…Save the date! Our next Network seminar will be on "Hearing voices, suicidality, and AI-psychosis", March 20th 2026, Hybrid
This is a collaboration with @hearingvoicesmic.bsky.social and #ProjectEPIC
Find more info and registration here:
birminghamphenomenalnetwork.blogspot.com/2025/12/netw...
@Drug_Science
blog on the new Compass #psilocybin for #depression study drugscience.org.uk/compass-phase3
And we're off to the races. Great lineup for today's @uobphenomenal.bsky.social seminar. Joined by speakers from Imperial, Exeter, Amsterdam, & Birmingham. #psychedelics #interdisciplinary #phenomenology #mentalhealth
🌿 Facing the end of life can bring immense distress. Could psychedelic therapy help ease the journey?
drugscience.org.uk/easing-end-of-life-distress-psychedelic-uk
@profjoneill.bsky.social, Laura Downey, & @profmq.bsky.social for @drugscience.bsky.social
#PalliativeCare #Psychedelics #DrugScience
Great day with rich discussions. The talks all went so well together. #psychedelics #phenomenology #mentalhealth @uobphenomenal.bsky.social
Psychiatric medicine is undergoing a seismic shift as Compass pathways announce successful results from its Phase 3 trial (COMP006).
Facing a terminal diagnosis is one of life’s most difficult challenges. Beyond the physical burden of illness, patients often experience anxiety, depression, insomnia, and existential distress – a sen...
Looking forward to the talks at our Psychedelics, Phenomenology, & Mental Health workshop as part of the Birmingham Network for Phenomenology & Mental Health. Sign up & schedule in the link.
Birmingham Network for Phenomenology and Mental Health
Pα+ Psychedelic Bulletin #207
- Lykos Rebrands to Resilient
- Pharma Pushes Back on Norway’s Ketamine Reimbursement Decision
- AbbVie-Gilgamesh Deal Viewed as Validation
- Psilocybin Rescheduling Petition Heads to HHS
- Much, much more...
psychedelicalpha.com/news/p%ce%b1...
PSYCHLES
Lykos Therapeutics Rebrands to Resilient Pharmaceuticals • Pharma Pushes Back on Norway’s Off-Label Ketamine Decision • AbbVie–Gilgamesh Deal Viewed as Validation for Short-Acting Psychedelics •
The Dutch Medicines Evaluation Board will host a Pipeline Meeting on 5 Nov 2025, focusing on the regulatory development of psychedelics.
Pharmaceutical companies can apply to present and discuss psychedelic development challenges with Dutch regulators.
Deadline: 29 Aug tinyurl.com/meb-pipeline...
A new excerpt from A World Appears: Minds Before Brains - by Michael Pollan - The Microdose themicrodose.substack.com/p/minds-befo...
🍄 Our new living systematic review and meta-analysis on psilocybin for depression is out. Here's what we found and the open science infrastructure we built to support it 🧪🧵
www.medrxiv.org/content/10.1...
josh hardman
PAREA
Michael Pollan
Our schedule for our next network seminar has now been finalised!
Check out our website for the full list of awesome talks:
birminghamphenomenalnetwork.blogspot.com/2025/10/netw...
P.S. there's still time to register!
Birmingham Network for Phenomenology and Mental Health
birminghamphenomenalnetwork.blogspot.com
The second seminar in the series organised by the Birmingham Network for Phenomenology and Mental Health will be held on 5 November 2025, 9....
đź“ŁAnnouncing our Psychedelics, Phenomenology, & Mental Health seminar, 5.11.25, Birmingham and Online
Drawing on phenomenological perspectives, the workshop will bring together interdisciplinary scholars to discuss the potential of psychedelic experiences for addressing mental health challenges.
